Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$235.51 - $267.98 $46,630 - $53,060
198 Added 388.24%
249 $12,000
Q1 2024

Jul 26, 2024

BUY
$224.58 - $256.19 $11,453 - $13,065
51 New
51 $13,000
Q2 2023

Aug 04, 2023

SELL
$224.99 - $256.14 $224 - $256
-1 Reduced 1.96%
50 $12,000
Q4 2022

Jan 30, 2023

BUY
$241.42 - $282.29 $241 - $282
1 Added 2.0%
51 $13,000
Q3 2022

Oct 31, 2022

BUY
$247.06 - $1507.4 $12,353 - $75,370
50 New
50 $12,000
Q2 2022

Aug 11, 2022

SELL
$237.11 - $299.66 $11,855 - $14,983
-50 Closed
0 $0
Q1 2022

Apr 29, 2022

SELL
$257.27 - $315.76 $257 - $315
-1 Reduced 1.96%
50 $14,000
Q4 2021

Jan 19, 2022

BUY
$292.08 - $329.01 $292 - $329
1 Added 2.0%
51 $17,000
Q3 2021

Oct 15, 2021

BUY
$272.21 - $332.43 $13,610 - $16,621
50 New
50 $15,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Mc Clarren Financial Advisors, Inc. Portfolio

Follow Mc Clarren Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Clarren Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Clarren Financial Advisors, Inc. with notifications on news.